![Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine: Molecular Therapy Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine: Molecular Therapy](https://www.cell.com/cms/asset/fb282b4e-87cf-4544-b03a-7510b259f329/fx1.jpg)
Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine: Molecular Therapy
![Frontiers | How far are the new wave of mRNA drugs from us? mRNA product current perspective and future development Frontiers | How far are the new wave of mRNA drugs from us? mRNA product current perspective and future development](https://www.frontiersin.org/files/Articles/974433/fimmu-13-974433-HTML-r1/image_m/fimmu-13-974433-g001.jpg)
Frontiers | How far are the new wave of mRNA drugs from us? mRNA product current perspective and future development
![Timothy Caulfield on X: "Great resource for answering #COVID19 #vaccine questions! via @NoahIvers @kgrindrod @Pharmacy5in5 ht @fauldscat cc @DrJenGunter @picardonhealth Useful responses re: ingredients, speed of development, long-term safety, & whether it Timothy Caulfield on X: "Great resource for answering #COVID19 #vaccine questions! via @NoahIvers @kgrindrod @Pharmacy5in5 ht @fauldscat cc @DrJenGunter @picardonhealth Useful responses re: ingredients, speed of development, long-term safety, & whether it](https://pbs.twimg.com/media/ErYhxpWVQAMJk1P.jpg)
Timothy Caulfield on X: "Great resource for answering #COVID19 #vaccine questions! via @NoahIvers @kgrindrod @Pharmacy5in5 ht @fauldscat cc @DrJenGunter @picardonhealth Useful responses re: ingredients, speed of development, long-term safety, & whether it
![A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2 | Nature Communications A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2 | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-021-21037-2/MediaObjects/41467_2021_21037_Fig4_HTML.png)
A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2 | Nature Communications
![A self-amplifying mRNA SARS-CoV-2 vaccine candidate induces safe and robust protective immunity in preclinical models: Molecular Therapy A self-amplifying mRNA SARS-CoV-2 vaccine candidate induces safe and robust protective immunity in preclinical models: Molecular Therapy](https://www.cell.com/cms/attachment/71e0677c-57e3-4f48-8ebf-b42c74b8c848/fx1_lrg.jpg)
A self-amplifying mRNA SARS-CoV-2 vaccine candidate induces safe and robust protective immunity in preclinical models: Molecular Therapy
![Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe - The Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe - The](https://www.thelancet.com/cms/attachment/27116734-900d-4f93-906c-61d126ea039b/gr1_lrg.jpg)
Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe - The
![Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors - The Lancet Oncology Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors - The Lancet Oncology](https://www.thelancet.com/cms/attachment/1b50e54c-826f-483e-99ae-7498698cfd92/gr1_lrg.jpg)
Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors - The Lancet Oncology
![A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2 | Nature Communications A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2 | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-21037-2/MediaObjects/41467_2021_21037_Fig1_HTML.png)
A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2 | Nature Communications
![Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trials | Infectious Diseases of Poverty | Full Text Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trials | Infectious Diseases of Poverty | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs40249-021-00878-5/MediaObjects/40249_2021_878_Figa_HTML.png)
Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trials | Infectious Diseases of Poverty | Full Text
![Florian Krammer on X: "For everybody worried that RNA vaccines are now tested for the first time in humans. That is actually not the case. See list below. It is true that Florian Krammer on X: "For everybody worried that RNA vaccines are now tested for the first time in humans. That is actually not the case. See list below. It is true that](https://pbs.twimg.com/media/Enx9aS_WMAEF9Mn.png)
Florian Krammer on X: "For everybody worried that RNA vaccines are now tested for the first time in humans. That is actually not the case. See list below. It is true that
![Long-term efficacy and safety of mRNA therapy in two murine models of methylmalonic acidemia - eBioMedicine Long-term efficacy and safety of mRNA therapy in two murine models of methylmalonic acidemia - eBioMedicine](https://www.thelancet.com/cms/asset/6656a1d3-128c-4be6-a82f-e75153651663/gr1.jpg)
Long-term efficacy and safety of mRNA therapy in two murine models of methylmalonic acidemia - eBioMedicine
![IJMS | Free Full-Text | Concern about the Effectiveness of mRNA Vaccination Technology and Its Long-Term Safety: Potential Interference on miRNA Machinery IJMS | Free Full-Text | Concern about the Effectiveness of mRNA Vaccination Technology and Its Long-Term Safety: Potential Interference on miRNA Machinery](https://www.mdpi.com/ijms/ijms-24-01404/article_deploy/html/images/ijms-24-01404-g001.png)